Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Perrone

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Pathology. Clinical Research|April 29, 2017
Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinomaAngelica Sonzogni, Fabrizio Bianchi, Alessandra Fabbri, et al.
Head & Neck|December 19, 2014
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancersLaura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
Future Oncology (London, England)|June 6, 2017
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumorsSara Pusceddu, Natalie Prinzi, Giuseppe Lo Russo, et al.
Endocrine-Related Cancer|November 8, 2012
DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cellsDebora Degl'Innocenti, Paola Romeo, Eva Tarantino, et al.
Clinical Genitourinary Cancer|November 8, 2017
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical ResearchAndrea Necchi, Salvatore Lo Vullo, Patrizia Giannatempo, et al.
Cancer Biomarkers : Section a of Disease Markers|August 7, 2023
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practiceAndrea Vingiani, Daniele Lorenzini, Elena Conca, et al.
Plos One|April 3, 2014
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type statusFilippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, et al.
Virchows Archiv : an International Journal of Pathology|January 29, 2016
Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sectionsGiuseppe Pelosi, Federica Perrone, Elena Tamborini, et al.
Frontiers in Oncology|January 27, 2022
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case ReportLaura Deborah Locati, Mara Serena Serafini, Andrea Carenzo, et al.
International Journal of Surgical Pathology|December 12, 2013
Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive casesGiuseppe Pelosi, Eva Regina Haspinger, Manuela Bimbatti, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Pathology. Clinical Research|April 29, 2017
Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinomaAngelica Sonzogni, Fabrizio Bianchi, Alessandra Fabbri, et al.
Head & Neck|December 19, 2014
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancersLaura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
Future Oncology (London, England)|June 6, 2017
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumorsSara Pusceddu, Natalie Prinzi, Giuseppe Lo Russo, et al.
Endocrine-Related Cancer|November 8, 2012
DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cellsDebora Degl'Innocenti, Paola Romeo, Eva Tarantino, et al.
Clinical Genitourinary Cancer|November 8, 2017
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical ResearchAndrea Necchi, Salvatore Lo Vullo, Patrizia Giannatempo, et al.
Cancer Biomarkers : Section a of Disease Markers|August 7, 2023
Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practiceAndrea Vingiani, Daniele Lorenzini, Elena Conca, et al.
Plos One|April 3, 2014
Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type statusFilippo Pietrantonio, Claudia Maggi, Maria Di Bartolomeo, et al.
Virchows Archiv : an International Journal of Pathology|January 29, 2016
Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sectionsGiuseppe Pelosi, Federica Perrone, Elena Tamborini, et al.
Frontiers in Oncology|January 27, 2022
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case ReportLaura Deborah Locati, Mara Serena Serafini, Andrea Carenzo, et al.
International Journal of Surgical Pathology|December 12, 2013
Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive casesGiuseppe Pelosi, Eva Regina Haspinger, Manuela Bimbatti, et al.
Pageof 16